Calcium lactate interference in measuring creatinine in peritoneal dialysis fluids by the Jaffé kinetic method.
Creatinine measurements in peritoneal dialysis fluids using the Jaffé method have poor specificity due to interfering substances. We have checked to see if calcium lactate, in addition to glucose, interferes with the Jaffé kinetic measurement. Eight samples were prepared with increasing concentrations of glucose (960-3890 mg/dL) and eight were prepared with the same glucose content plus 7 mg/dL of calcium lactate, all without creatinine; in addition, 96 samples with increasing concentrations of glucose (1500-4000 mg/dL), calcium lactate (3-7.5 mg/dL), and creatinine (0.75-4.5 mg/dL) were prepared. There was a 0.31 +/- 0.13 mg/dL glucose interference on the Jaffé kinetic measurement in the first series, with an exponential trend. Interference was greater with calcium lactate and glucose: 0.50 +/- 0.16 mg/dL with the same trend. Data from the second series confirm the overestimation: 0.54 +/- 0.05 mg/dL (32.6%) with an exponential trend. The interference of glucose, creatinine, and calcium lactate on the Jaffé kinetic measurement was obtained by multi-variate regression. The single effects of glucose2 and glucose are predominant, but both creatinine and calcium lactate have a significant effect. Our study highlights the nonlinear glucose interference on creatinine measurement with the Jaffé kinetic method and the linear interference of both calcium lactate and creatinine.
Amici
G
G
Nephrology Division, Regional Hospital S. Maria dei Battuti, Treviso, Italy.
Da Rin
G
G
Bardin
C
C
Gatti
P L
PL
Calconi
G
G
Bocci
C
C
D003404:Creatinine / Q000097:blood*; D015314:Dialysis Solutions / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D005950:Glucose Solution, Hypertonic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D007700:Kinetics; D019344:Lactic Acid / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010530:Peritoneal Dialysis; D012680:Sensitivity and Specificity
D015314:Dialysis Solutions; D005950:Glucose Solution, Hypertonic; D019344:Lactic Acid; D003404:Creatinine